Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of remifentanil on stress response during general anesthesia induction
ChiCTR2400090610Phase 4Not yet recruiting
- Sponsor
- Jianyang People's Hospital
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in surgical stress (3 arms), sponsored by Jianyang People's Hospital. Primary endpoint: Percentage change in cortisol levels after intubation (T1) and before incision (T2). Planned start Oct 2024; status: not yet recruiting.
02
Drugs
remifentanil
03
Conditions
surgical stress
Beyond the preview
Go deeper on ChiCTR2400090610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090610.